New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.
Translational Oncology(2023)
摘要
•This editorial provides a brief overview of the role of HDACs in diffuse large B-cell lymphoma (DLBCL).•Possible mechanisms of HDAC inhibitor resistance in DLBCL are discussed in detail.•It highlights the need for developing HDAC isoform-specific inhibitors.•Additional combinatory regimens and dual-specificity inhibitors may increase the therapeutic efficacy of HDAC inhibition in this aggressive lymphoma.
更多查看译文
关键词
Epigenetics,Histone deacetylation,Histone deacetylation inhibitors,DLBCL,Resistance mechanism
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要